Cargando…

Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles

We present a case of multiple primary lung cancer(MPLC) displaying heterogeneous EGFR and PTEN molecular profiles. Considering the physical condition of patients, the patient underwent surgical resection of the right lung lesion displaying gefitinib-insensitive and continued gefitinib treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhouyu, Yu, Tao, Chai, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348444/ https://www.ncbi.nlm.nih.gov/pubmed/27823967 http://dx.doi.org/10.18632/oncotarget.13046

Ejemplares similares

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles
por: Zhu, Zhouyu, et al.
Publicado: (2022)

First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations with Postoperative Intrapulmonary Recurrence
por: Zhu, Zhouyu, et al.
Publicado: (2021)

Early Multiple Primary Lung Cancer without Fluorodeoxyglucose Uptake on Positron Emission Tomography-Computed Tomography and Displaying Different EGFR Molecular Profiles
por: Liu, Chang, et al.
Publicado: (2017)

Complete remission of liver metastasis in a lung cancer patient with epidermal growth factor mutation achieved with Icotinib
por: Zhu, Zhouyu, et al.
Publicado: (2016)

Crizotinib resistance overcome by ceritinib in an ALK-positive non-small cell lung cancer patient with brain metastases: A case report
por: Zhu, Zhouyu, et al.
Publicado: (2017)

Tonsillar metastasis of nonsmall cell lung cancer with G719S mutation in exon 18: A case report
por: Wu, Yimin, et al.
Publicado: (2017)

Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?
por: Qu, Rirong, et al.
Publicado: (2021)

Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: A case report
por: Yao, Yufeng, et al.
Publicado: (2018)

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations
por: Qu, Rirong, et al.
Publicado: (2022)

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
por: Ye, Chenyang, et al.
Publicado: (2016)

Different EGFR gene mutations in two patients with synchronous multiple lung cancers: A case report
por: Sakai, Hiroki, et al.
Publicado: (2017)

Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer
por: Li, Chunxiang, et al.
Publicado: (2021)

Imaging of synchronous multiple primary lung adenocarcinoma with concomitant EGFR and KRAS mutations: a case report and review of the literature
por: Ma, Jing-Wen, et al.
Publicado: (2021)

Pten-NOLC1 Fusion Promotes Cancers Involving MET and EGFR Signalings
por: Luo, Jian-Hua, et al.
Publicado: (2020)

Synchronous multiple primary lung cancers with shared EGFR mutation but differential imaging findings and pathological subtypes: A case report
por: Su, Lei, et al.
Publicado: (2020)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Molecular Evolution of PTEN Pseudogenes in Mammals
por: Tang, Jingsi, et al.
Publicado: (2016)

PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers
por: Won, Hye Sung, et al.
Publicado: (2019)

A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
por: Liao, Che-Chi, et al.
Publicado: (2020)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

Lung Molecular Cytopathology: EGFR and Beyond
por: Jain, Deepali
Publicado: (2019)

Case report: primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
por: Zheng, Lin-Peng, et al.
Publicado: (2018)

EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
por: Chang, Hyun, et al.
Publicado: (2016)

Co-Occurring EGFR S645C and EGFR L858R in a Patient with Lung Adenocarcinoma Induced Primary Resistance to Osimertinib
por: Wang, Li, et al.
Publicado: (2023)

Multiple primary chordomas of the lung
por: Ohya, Maki, et al.
Publicado: (2018)

Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012)

PTEN modulates EGFR late endocytic trafficking and degradation by dephosphorylating Rab7
por: Shinde, Swapnil Rohidas, et al.
Publicado: (2016)

Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer
por: Kappler, Christiana S., et al.
Publicado: (2014)

CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas
por: Han, Xiaoyu, et al.
Publicado: (2020)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment
por: Xie, Shaonan, et al.
Publicado: (2022)

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
por: Wang, Shuhang, et al.
Publicado: (2015)

Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient
por: Tao, Junyan, et al.
Publicado: (2020)

Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
por: Chen, Yu, et al.
Publicado: (2015)

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
por: She, Qing-Bai, et al.
Publicado: (2016)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
por: Xu, Hui, et al.
Publicado: (2020)

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
por: Huang, Yen-Hsiang, et al.
Publicado: (2022)

Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: Case report
por: Vasovčák, Peter, et al.
Publicado: (2011)

Molecular Analysis of AFP and HSA Interactions with PTEN Protein
por: Zhu, Mingyue, et al.
Publicado: (2015)

Recurrent retroperitoneal Schwannomas displaying different differentiation from primary tumor: Case report and literature review
por: Li, Zhong-qi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3o5fss929ch868c0075lotjflm